• Conducted a survey to
study patient care and satisfaction parameters as part of final year project in healthcare coordination.
• Provide
study patients a caring and open communications while obtaining blood samples and process specimens following study protocol and laboratory instructions and procedures.
Not exact matches
A new
study published in the New England Journal of Medicine finds that Valeant Pharmaceuticals» infamous price hikes for a pair of heart drugs called nitroprusside and isoproterenol — whose prices were increased by 310 % and 720 %, respectively — had significant downstream effects on
patient care.
We have now completed several health
studies in partnership with the Geisinger Health System, which provides primary
care to over 450,000
patients in Pennsylvania, including many residing in fracking areas.
In health
care, this amounts to an hourly avalanche of new research papers, clinical trials, scientific
studies, and
patient health information.
The
study, published today in the journal Trauma Surgery & Acute
Care Open, found most of the fictional
patients (71 %) were transferred from emergency directly to the operating theatre.
The company points to a simple resource allocation problem that's hindered the most effective
patient care: the fact that it is physically impossible for oncologists to keep track of every
study, every clinical trial, and every breakthrough in the wildly stratified world of cancer research.
«ICU
care is inefficient, devoting substantial resources to
patients less likely to benefit,» their
study, published in the February edition of JAMA Internal Medicine, concluded.
«Our
study demonstrates the power of mobile health tools to scale and accelerate clinical research so that we can derive the evidence needed to inform clinical practice and improve
patient care,» she said.
We are pleased that increasing numbers of physicians are prescribing Vascepa to help their
patients and we are confident that the results from the REDUCE - IT
study will lead to better informed decisions regarding
patient care.»
The National Institutes for Health also brought on six health -
care groups in smaller cities to expand the
study's reach and ensure a diverse roster of
patients.
These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror
patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable
Care Act or other government action that could have the effect of lowering prices or reducing the number of insured
patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and
patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical
studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).
Attendees will learn through case
studies how a PBM can engage all
care stakeholders collaboratively - prescribers at the point of
care (PoC), pharmacists at the point of sale (PoS),
patients, and payers» clinical / pharmacy staff to reduce overall pharmacy costs and avoidable drug — impacted medical costs while improving compliance and
patients» quality of life.
Attendees will learn through case
studies how a PBM can engage all
care stakeholders collaboratively — prescribers at the point of
care (PoC), pharmacists at the point of sale (PoS),
patients, and payers» clinical / pharmacy staff to reduce overall pharmacy costs and avoidable drug - impacted medical costs while improving compliance and
patients» quality of life.
As Gawande notes, a
study conducted by Aetna Insurance permitting «concurrent
care» — having access to both hospice and life - extending treatments — saw hospice participation rise from 26 to 70 percent of eligible
patients.
About 1971, however, there was a major turn in my pilgrimage as I gradually became painfully aware of the so - called outcome
studies reporting the dubious effectiveness of average psychotherapy, whose cure rates barely match spontaneous remission, coupled with the frightening spectre of client deterioration (i.e.,
patients finding their condition worsening under the
care of professional psychotherapists).
Sanders, D.S., M.J. Carter, D.P. Hurlstone, et al., «Association of Adult Coeliac Disease With Irritable Bowel Syndrome: A Case - Control
Study in
Patients Fulfilling ROME II Criteria Referred to Secondary
Care,» Lancet, 358:1504 - 1508, 2001.
For the purposes of this economic evaluation, the forms were initially used in a related
study funded by the National Institute of Health Research (NIHR) research for
patient benefit programme «assessing the impact of a new birth centre on choice and outcome of maternity
care in an inner city area,» which will be reported in full elsewhere, comparing the costs of
care in a free standing midwifery unit with
care in an obstetric unit in the same trust.16 The data collected included details of staffing levels, treatments, surgeries, diagnostic imaging tests, scans, drugs, and other resource inputs associated with each stage of the pathway through intrapartum and after birth
care.
In a
study of 1,237 hospitals and residential health
care homes researchers found that 3.4 % of
patients were infected with MRSA.
In addition she
studies the relationship between nursing practice and parent and infant outcomes; nurse -
patient interaction; the health
care work environment and provider and
patient outcomes; and system and culture change in health
care.
Because of heterogeneity in the primary
studies, neither the meta - analyses nor the comprehensive review assessed
patient and obstetrician or obstetric
care provider satisfaction and improved knowledge of childbirth, family planning, postpartum depression, or early child rearing.
«Previous
studies have also noted that the financial condition of the most troubled institutions is, to a large extent, a product of an inefficient expense structure, revenue challenges associated with a
patient mix that approaches 90 percent public payers and charity
care, and overwhelming liabilities (including debt issued long ago for physical plant improvements that, in some cases, are obsolete),» the health department said in its announcement.
Erie County and each Mall partner are teaming up with the University at Buffalo's School of Public Health to conduct long - term
studies of the health outcomes and health
care utilization of
patients who visit the Health Mall.
«Council
studies show that institutions that are adequately staffed have better quality of
care, are more profitable,
patients suffer fewer infections and there are fewer deaths.
With expertise in minimally invasive oncoplastic breast surgery, Dr. Wilson has also
studied complementary medicine and provides her
patients with a holistic, integrative approach to breast
care.
«Virtual house calls for chronic diseases like Parkinson's are not only as effective as in - person
care but broader adoption of this technology has the potential to expand access to
patient - centered
care,» said Ray Dorsey, M.D., the David M. Levy Professor of Neurology at the University of Rochester Medical Center (URMC) and lead author of the
study.
Despite a growing interest in comparative effectiveness research, little medical
study is being done to improve this aspect of
patient care
The goal of the Connect.Parkinson
study was to see if telemedicine would allow neurologists to deliver
care to
patients in the comfort of their homes.
«ICU
care is inefficient, devoting substantial resources to
patients less likely to benefit,» their
study, published in the February edition of JAMA Internal Medicine, concluded.
The
study found the impact of oral nutritional supplements on length of stay and cost of
care were even more impactful and statistically significant when looking at all Medicare
patients aged 65 and older with any primary diagnosis:
In a
study from the University of Pennsylvania School of Nursing (Penn Nursing), a new, simplified Braden QD Scale now describes combined immobility - related and MDPI risk in a broader, more diverse sample of pediatric
patients typically
cared for in acute
care environments.
In one routine -
care study, reported in 2013 in Annals of Internal Medicine, 8 percent of
patients stopped taking statins because of side effects.
A new
study entitled «Oral Nutrition Supplements» Impact on Hospital Outcomes in the Context of Affordable
Care Act and New Medicare Reimbursement Policies» and conducted by leading researchers at the University of Southern California, Stanford University, The Harris School at The University of Chicago and Precision Health Economics, and supported by Abbott, found that the use of oral nutritional supplements decreased the probability of 30 - day hospital readmission, length of stay and costs among hospitalized Medicare
patients aged 65 and over.
«Hospitals are going to be looking for ways to improve quality of
care for Medicare
patients in order to lower readmission rates and prevent fines,» said
study co-author, Tomas Philipson, Ph.D., who is the Daniel Levin Chair of Public Policy at the University of Chicago.
In the
study,
patients who underwent conscious sedation had a similar rate of adverse events to those who underwent anesthesia, but those who were given conscious sedation had shorter stays in the intensive
care unit (30 versus 96 hours for those with general anesthesia) and shorter hospital stays (4.9 days versus 10.4 days).
«A significant body of research has resulted in a shift from thinking of placebos as just «dummy» treatments to recognizing that placebo effects encompass numerous aspects of the health
care experience and are central to medicine and
patient care,» said the article's coauthor Ted Kaptchuk, Director of the Program in Placebo
Studies at Beth Israel Deaconess Medical Center (BIDMC) and Professor of Medicine at Harvard Medical School.
The NAPOLI - 1 (NAnoliPOsomaL Irinotecan) Phase 3
study — a final confirmation of a drug's safety and effectiveness — was conducted among
patients with metastatic pancreatic cancer who previously received gemcitibine, which has been the standard - of -
care therapy for such
patients.
Under Litofsky's mentorship, Kristen Scheitler - Ring, a medical student doing a pathology fellowship at the MU School of Medicine,
studied the outcomes of
patients treated at MU Health
Care from 2010 to 2014.
In this
study in a Berlin hospital, one
patient in five receiving routine
care suffered from postoperative delirium, whereas in the group receiving support from delirium liaison nurses, fewer than 1 in 20 developed cognitive disorders.
«We believe these
studies and clinical trials that combine immunotherapy with chemotherapy are advancing efforts toward better clinical
care and more positive outcomes for our
patients at CTCA,» said Dr. Vivek Khemka, Medical Oncologist, CTCA at Western and the WCLC
study abstract's principal investigator and senior author.
In observational
studies, researchers observe exposures and outcomes for
patients as they occur naturally in clinical
care or real life.
According to a July 2012
study of 400 primary
care patients (published by Miller and her colleagues in the popular family practice journal Annals of Family Medicine), 22 percent of individuals with chronic health issues suffer from some degree of chemical intolerance.
A report of the
study, published in the journal JAMA Dermatology April 28, suggests that identifying and informing high outlier physicians of their extreme practice patterns can enable targeted re-training, potentially sparing
patients from substandard
care.
«By
studying the issue of variation in practice patterns, the Mohs College hopes to improve the quality and value of
care we provide our
patients.»
In the
study, researchers from the Perelman School of Medicine at the University of Pennsylvania programmed electronic health records (EHR) to alert
care providers when a
patient was eligible, and prompt them to choose to «accept» or «decline» a flu vaccination order.
Prior
studies suggested that tPA benefited frostbite
patients as well, but this is the first time its potential was compared with established
care alone.
The
study included all
patients aged 65 years and older admitted to two cardiac intensive
care units during a period of 15 months.
The
study used nationwide data on 836
patients newly diagnosed with ulcerative colitis in the Veterans Affairs (VA) health
care system from 2001 to 2011.
In the
study, Litt's team at MU Health
Care used a recently developed autograft harvesting system to care for 13 patients with various types of chronic wou
Care used a recently developed autograft harvesting system to
care for 13 patients with various types of chronic wou
care for 13
patients with various types of chronic wounds.
As the United States grapples with what many believe is a crisis of spiraling health
care costs, this
study, while focused on one hospital and 100
patients, shows that when health
care consumers are given pricing information, they will take costs into account.